| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1990 Oxford University Press
other |
Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms
1Department of Pathology, Gifu University School of Medicine 40 Tsukasamachu, Gifu 500
3Faculty of Home Economics, Chukyo Women's University Ohbu 474, Japan
2To whom correspondence should be addressed
The carcinogenic potential of 1-hydroxyanthraquinone (HA), a naturally occurring compound, was examined. A total of 60 male ACI/IN rats, 1.5 months old at the commencement were divided into two groups. Group 1 (30 rats) were fed the diet containing HA at a concentration of 1% throughout the experIment (480 days). Group 2(30 rats) served as the control given a basal diet alone. Twenty-five of 29 effective animals in group 1 developed adenomas or adenocarcinomas in the cecum or upper portion of the colon, the mean number of large bowel tumors/tumor bearing rat being 2.3. In addition to these intestinal tumors, liver neoplasms (neoplastic nodules and hepatocellular carcinomas) were observed in 12 rats and benign stomach tumors were obtained in five animals; no rats of group 2 demonstrating development of any of these tumor types. The incidences of the large bowel, liver and stomach neoplasms in group 1 were all significant as compared with group 2 (P < 2 x 1013, P < 5 x 105 and P < 3 x 102 respectively) clearly indicating that HA is carcinogenic in rats.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. E. Butterworth, O. B. Mathre, K. E. Ballinger, and O. Adalsteinsson Contamination Is a Frequent Confounding Factor in Toxicology Studies with Anthraquinone and Related Compounds International Journal of Toxicology, September 1, 2004; 23(5): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nascimbeni, F. Donato, M. Ghirardi, P. Mariani, V. Villanacci, and B. Salerni Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon Cancer: A Risk Assessment Using Aberrant Crypt Foci Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 753 - 757. [Abstract] [Full Text] [PDF] |
||||

